Cost-effectiveness of vasopressin in the treatment of septic shock: insights from a European societal perspective

Second-line VA is a cost-effective intervention for septic shock, notably when initiated early. These findings support guideline recommendations for early vasopressor use and emphasize the clinical and economic value of timely VA therapy.